연조직 증강을 위한 세포치료 시 비계로서 키토산의 온도 감응성 및 섬유모세포의 증식에 미치는 영향에 관한 연구

STUDY ON THERMOSENSITIVITY OF CHITOSAN SCAFFOLD AND ON ITS EFFECTS ON FIBROBLAST PROLIFERATION IN CELL THERAPY FOR SOFT TISSUE AUGMENTATION

  • 김정호 (서울대학교 치과대학 구강악안면외과학교실) ;
  • 최진영 (서울대학교 치과대학 구강악안면외과학교실)
  • Kim, Jung-Ho (Department of Oral and Maxillofacial Surgery, College of dentistry, Seoul National University) ;
  • Choi, Jin-Young (Department of Oral and Maxillofacial Surgery, College of dentistry, Seoul National University)
  • 발행 : 2009.06.30

초록

Traditional surgical method or injection using filler is performed for soft tissue augmentation. Surgical methods have disadvantage of surgical morbidity. Commercially available injectable materials have the disadvantages such as resorption, short-term effect. repeated application and hypersensitivity. Significant shortcoming of cell therapy using autologous fibroblasts is delay of treatment effect. Chitosan/${\beta}$-glycerol phosphate (GP) solution has thermosensitive property and allows sol-gel transition at physiologic pH and temperature. These properties may resolve the delay of treatment effect. The purposes of this study are to evaluate the viscosity and pH changes of chitosan/${\beta}$-GP solutions and to evaluate the effect of chitosan/${\beta}$-GP solution on fibroblast proliferation and production of collagen. We measured the viscosity and pH as function of temperature, of the solution containing 1:0.7, 1:0.75, 1:0.8 chitosan (1, 10, 100, 700 kDa) /${\beta}$-GP. Fibroblasts from ears of 5 rats were cultured in chitosan/${\beta}$-GP solutions for 3 weeks. Cell proliferation and collagen contents were measured every week with WST (water-soluble tetrazolium salt) assay and Collagen assay respectively. The Results are 1) Chitosan(100 kDa<)/${\beta}$-GP solution (1:0.75) showed sol-gel transition at physiologic pH and body temperature and injectable properties. It will enable to resolve the delay in treatment effect 2) Cell proliferation and total collagen contents of the control group were increased with time. However, these decreased after the 1st week in experimental group 3) Collagen contents in the experimental group are higher than that of control group. Chitosan/${\beta}$-GP solution may provide favorable conditions for cell function

키워드

참고문헌

  1. Homicz MR, Waston D. Review of injectable materials for softtissue augmentation. Facial Plast Surg 2004;20:21-9 https://doi.org/10.1055/s-2004-822955
  2. Cheng JT, Perkins SW, Hamilton M. Collagen and injectablefiller. Otolaryngol Clin North Am 2002;35:73-85 https://doi.org/10.1016/S0030-6665(03)00095-1
  3. Faigen S. Facial soft tissue augmentation with injectable autologousand allogenic human tissue collagen matrix (autologen anddermalogen). Plast Reconstr Surg 2000;105:362-73 https://doi.org/10.1097/00006534-200001000-00057
  4. Mak K, Toriumi D. Injectable filler materials for soft tissue augmentation.Otolayngol Clin North Am 1994;27:211-22
  5. Framer FM, Churukium MM. Clinical use of injectable collagen:a three-year retrospective review. Arch Otolayngol 1984;110:93-8 https://doi.org/10.1001/archotol.1984.00800280027008
  6. Cooperman LS, Makinnon V, Bechler G, Phariss BB. Injectablecollagen: a six-year clinical investigation. Asthet Plast Surg1985;9:145-51 https://doi.org/10.1007/BF01570347
  7. Krauss M. Recent advances in soft tissue augmentation. SeminCutan Med Surg 1999;18:119-28 https://doi.org/10.1016/S1085-5629(99)80036-4
  8. Bousquet MT, Agerup B. Restylane lip implantation: European experience. Operat Tech Oculoplast Orbital Reconstr Surg1999;2:172-6
  9. Cantisano-Zilkha M, Bosniak S. Hyaluronic acid gel injections for facial rejuvenation: 3-year clinical experience. Operat TechOculoplast Orbital Reconstr Surg 1999;2:177-81
  10. Maas C. Characteristics of implant materials. Arch Facial Plast Surg 2000;2:67
  11. Parker F. Structure and function of the skin. In: Orkin M,Mail-bach HI, Dahl MV, eds. Dermatology. San Mateo,CA:Appleton and Lange: 1991:1-14
  12. Boss WK, Usal H, Fodor PB, Chernoff G. Autologous culturedfib-roblasts: a protein repair system. Ann Plast Surg2000;44:536-42 https://doi.org/10.1097/00000637-200044050-00013
  13. Waston D, Keller GS, Lacombe V, et al. Autologous fibroblast fortreatment of facial rhytids and dermal depressions. Arch Facial Plast Surg 1999;1:165-70 https://doi.org/10.1001/archfaci.1.3.165
  14. Weiss RA, Weiss MA, Beasley KL, Munavalli G. Autologous culturedfibroblasts injection for facial contour deformities: Aprospective, placebo-controlled, phase III clinical trial. Dermatol Surg 2007;33:263-8 https://doi.org/10.1111/j.1524-4725.2007.33060.x
  15. Yang S, Leong K-F, Du Z, Chua C-K. The design of scaffold foruse in tissue engineering. Part I. Traditional factor. Tissue Eng2001;7:679-89 https://doi.org/10.1089/107632701753337645
  16. Park JB, Lakes RS. Biomaterials: an introduction, 2nd ed. NewYork: Plenum Press; 1992
  17. Lee KY, Mooney DJ. Hydrogels for tissue engineering. ChemRev 2001;101:1869-77 https://doi.org/10.1021/cr000108x
  18. Ruel-Gariepy E, Leroux J-C. In situ-forming hydrogels - reviewof temperature-sensitive systems. Eur J Pharm and Bio pharm 2004;58:409-26 https://doi.org/10.1016/j.ejpb.2004.03.019
  19. Drury JL, Mooney D. Hydrogels for tissue engineering: scaffolddesign variables and applications. Biomaterials 2003;24:4337-51 https://doi.org/10.1016/S0142-9612(03)00340-5
  20. Chenite A, Buschmann M, Wang D, Chaput C, Kandani N. Rheologicalcharacterisation of thermogelling chitosan/glycerol-phosphatesolutions. Carbohydrate Polymers 2001;46:39-47 https://doi.org/10.1016/S0144-8617(00)00281-2
  21. Martini AD, Sittinger M, Risbud MV. Chitosan: A versatile biopolymerfor orthopaedic tissue-engineering. Biomaterials 2005;26:5983-90 https://doi.org/10.1016/j.biomaterials.2005.03.016
  22. Molinaro G, Leroux JC, Damas J, Adam A. Biocompatibility ofthermosensitive chitosan-based hydrogels: an in vivo experimentalapproach to injectable biomaterials. Biomaterials 2002;23:2717-22 https://doi.org/10.1016/S0142-9612(02)00004-2
  23. Chenite A, Chaput C, Wang D, Combes C, Buschmann M,Hoemann CD, et al. Novel injectable neutral solutions of chitosanfrom biodegradable gels in situ. Biomaterials 2000;21:2155-61 https://doi.org/10.1016/S0142-9612(00)00116-2
  24. Jarry C, Chaput C, Chenite A, Renaud MA, Buschmann M,Leourx JC. Effect of steam sterilization on thermogelling chitosan-based gells. J Biomed Mater Res 2001;58:127-35 https://doi.org/10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
  25. Ruel-Gariepy E, Chenite A, Chaput C, Guirguis S, Leourx JC.Characterization of thermosensitive chitosan gels for the sustaineddelivery of drugs. Int J Pharma 2000;203:89-98 https://doi.org/10.1016/S0378-5173(00)00428-2
  26. Ma L, Gao C, Mao Z, Zhou J, Shen J, Hu X, et al. Collagen/ chitosanporous scaffolds with improved biostability for skin tissueengineering. Biomaterials 2003;24:4833-41 https://doi.org/10.1016/S0142-9612(03)00374-0
  27. Hockin HK, Simon Jr CG. Fast setting calcium phosphate-chitosanscaffold: mechanical properties and biocompatibility.Biomaterials 2005;26:1337-48 https://doi.org/10.1016/j.biomaterials.2004.04.043
  28. Ho MH, Kuo PY, Hsieh HJ, Hsien TY, Hou LT, Lai JY, et al.Preparation of porous scaffolds by using freeze-extraction andfreeze-gelation methods. Biomaterials 2004;25:129-38 https://doi.org/10.1016/S0142-9612(03)00483-6
  29. Jarry C, Leourx JC, Haeck J, Chaput C. Irradiating or autoclavingchitosan/polyol solutions: Effect on thermogelling chitosan-$\beta$-glycero phosphate systems. Chem. Pharm. Bull. 2002;50:1335-440 https://doi.org/10.1248/cpb.50.1335
  30. Rwei SP, Chen TY, Cheng YY. Sol/gel transition of chitosan solutions.J Biomater Sci Polym Ed. 2005;16:1433-45 https://doi.org/10.1163/156856205774472290
  31. Cho J, Heuzey MC, Begin A, Carreau PJ. Physical gelation ofchi-tosan in the presence of beta-glycerophosphate: the effect oftem-perature. Biomacromolecules. 2005;6:3267-75 https://doi.org/10.1021/bm050313s
  32. Karlstrom G, Carlsson A, Lindman B. Phase diagram of nonionicpolymer-water systems. Experimental and theoretical studies ofthe effects of surfactants and other cosolutes. J Physical Chem1990;94:5005-15 https://doi.org/10.1021/j100375a045
  33. Gekko K, Mighishima H, Koga S. Effects of sugars and polyolson the sol-gel transition of k-carrageenan: calorimetric study. IntJ Biologic Macromole 1987;9:146-52 https://doi.org/10.1016/0141-8130(87)90042-0
  34. Shively ML, Coonts BA, Renner WD, Southard JL, Bennet AT.Physico-chemical characterization of a polymeric injectable implantdelivery system. J Control. Release 1995;33:237-43 https://doi.org/10.1016/0168-3659(94)00097-E
  35. Haglund BO, Joshi R, Himmelstein KJ. An in situ gelling systemfor parenteral delivery. J Control. Release 1996;41:229-35 https://doi.org/10.1016/0168-3659(96)01333-8
  36. Eliaz RE, Szoka FC. Robust and prolonged gene expression frominjectable polymeric implants. Gene Ther 2002;9:1230-7 https://doi.org/10.1038/sj.gt.3301786
  37. Ono K, Saito Y, Yura H, Ishikawa K, Kurita A, Akaike T, et al.Photocrosslinkable chitosan as a biological adhesive. J BiomedMater Res. 2000;49:289-95 https://doi.org/10.1002/(SICI)1097-4636(200002)49:2<289::AID-JBM18>3.0.CO;2-M
  38. Burkoth AK, Anseth KS. A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials 2000;21:2395-404 https://doi.org/10.1016/S0142-9612(00)00107-1
  39. Freyman TM, Tannas IV, Gibson LJ. Cellular materials as porousscaffolds for tissue engineering. Progr Mater Sci 2001;46:273-82 https://doi.org/10.1016/S0079-6425(00)00018-9
  40. Chen GP, Ushida Y, Tateishi T. Scaffold design for tissue engineering. Macromolecular Biosci 2002;2:67-77 https://doi.org/10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
  41. Lee KY, Ha WS, Park WH. Blood compatibility and biodegradabilityof partially N-acetylated chitosan derivatives. Biomaterials1995;16:1211-6 https://doi.org/10.1016/0142-9612(95)98126-Y
  42. Mi FL, Kuan CY, Shyu SS, Lee ST, Chang SF. The study of gelation kinetics of chain-relaxation properties of glutaraldehyde-cross-linked chitosan gel and drug release. Carbohydr Polym 2000;41:389-96 https://doi.org/10.1016/S0144-8617(99)00104-6
  43. Smidsrod O, Skjak-Braek G. Alginate as immobilization matrixfor cells . Trends Biotech 1990;8:71-8 https://doi.org/10.1016/0167-7799(90)90139-O
  44. Lu S, Anesth KS. Release behavior of high molecular weight solute from poly(ethylene glycol)-based degradable networks.Macro-molecules 2000;33:2509-15 https://doi.org/10.1021/ma9915024
  45. Madihally SV, Matthew HWT. Porous chitosan scaffold for tissueengineering. Biomaterials 1999;20:1133-42 https://doi.org/10.1016/S0142-9612(99)00011-3
  46. Bent AE, Tutrone RT, Mclennan MT, Lioyd LK, Kennelly MJ,Badlani G. Treatment of intrinsic sphincter deficiency using auto-logous ear chondrocyte as a bulking agent. NeurourolUrodynam 2001;20:157-65 https://doi.org/10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A